Herpes treatment may limit HIV transmission and progression.
Wilkinson
Emma
E
D000212:Acyclovir / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D018450:Disease Progression; D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D005260:Female; D005836:Genitalia, Female / Q000821:virology; D015658:HIV Infections / Q000150:complications / Q000473:pathology / Q000635:transmission* / Q000821:virology; D015497:HIV-1 / Q000235:genetics / Q000302:isolation & purification*; D006561:Herpes Simplex / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D012367:RNA, Viral / Q000097:blood / Q000302:isolation & purification; D013997:Time Factors; D000077483:Valacyclovir; D014633:Valine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019562:Viral Load
D000998:Antiviral Agents; D012367:RNA, Viral; D014633:Valine; D000077483:Valacyclovir; D000212:Acyclovir